HANCOCK JOHN WORLD FUND
NSAR-B, EX-27, 2000-12-28
Previous: HANCOCK JOHN WORLD FUND, NSAR-B, EX-27, 2000-12-28
Next: HANCOCK JOHN WORLD FUND, NSAR-B, EX-27, 2000-12-28



<TABLE> <S> <C>

<ARTICLE> 6
<SERIES>
   <NUMBER> 033
   <NAME> JOHN HANCOCK HEALTH SCIENCES FUND-CLASS C

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             NOV-01-1999
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                      428,611,907
<INVESTMENTS-AT-VALUE>                     556,440,512
<RECEIVABLES>                                4,837,128
<ASSETS-OTHER>                                  10,843
<OTHER-ITEMS-ASSETS>                           117,352
<TOTAL-ASSETS>                             561,405,835
<PAYABLE-FOR-SECURITIES>                    19,231,744
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                   56,132,723
<TOTAL-LIABILITIES>                         75,364,467
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                   324,064,679
<SHARES-COMMON-STOCK>                          301,200
<SHARES-COMMON-PRIOR>                           57,160
<ACCUMULATED-NII-CURRENT>                      (3,804)
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                     34,152,262
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                   127,828,231
<NET-ASSETS>                               486,041,368
<DIVIDEND-INCOME>                            1,707,192
<INTEREST-INCOME>                              820,701
<OTHER-INCOME>                                 189,993
<EXPENSES-NET>                               7,065,819
<NET-INVESTMENT-INCOME>                    (4,347,933)
<REALIZED-GAINS-CURRENT>                    55,595,068
<APPREC-INCREASE-CURRENT>                   72,711,700
<NET-CHANGE-FROM-OPS>                      123,958,835
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        289,772
<NUMBER-OF-SHARES-REDEEMED>                     45,732
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                     239,075,471
<ACCUMULATED-NII-PRIOR>                        (2,773)
<ACCUMULATED-GAINS-PRIOR>                  (7,405,866)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                        2,741,156
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                              7,065,819
<AVERAGE-NET-ASSETS>                         8,057,245
<PER-SHARE-NAV-BEGIN>                            32.83
<PER-SHARE-NII>                                 (0.64)
<PER-SHARE-GAIN-APPREC>                          15.36
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              47.55
<EXPENSE-RATIO>                                   2.20



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission